Showing 81 - 90 of 366,654
We examine whether medical innovation can reinforce existing health disparities by disproportionately benefiting socioeconomically advantaged patients. The reason is that less advantaged patients often do not use new medications. This may be due to high costs of new drugs, but could also reflect...
Persistent link: https://www.econbiz.de/10012533413
Although influenza vaccine shortage is often attributed to low supply, it has been observed that even with abundant supply, a major shortage can still occur due to late delivery. In this paper, motivated by the influenza vaccine industry, we study a supply chain contracting problem in the...
Persistent link: https://www.econbiz.de/10014039787
Background: Healthcare personnel (HCP) are a priority group for annual influenza vaccination. Few studies have assessed the validity of recall of prior influenza vaccination status among HCP, especially for more than one preceding season.Methods: Using data from a randomized controlled trial of...
Persistent link: https://www.econbiz.de/10013308372
Persistent link: https://www.econbiz.de/10014368785
Persistent link: https://www.econbiz.de/10014296486
Persistent link: https://www.econbiz.de/10014375270
Many US cities implemented indoor vaccine mandates to incentivize citizens to get vaccinated and reduce the spread of COVID-19. Previous research finds that similar country-level mandates increased vaccine uptake substantially. However, with city-level mandates, unvaccinated individuals could...
Persistent link: https://www.econbiz.de/10014259526
Persistent link: https://www.econbiz.de/10012610771
We analyze the effects of a vaccination program providing free flu vaccine to individuals aged 65 or more on take-up behavior and hospitalization. Using both administrative and survey data, we implement a regression discontinuity design around the threshold at age 65, and find that the effect of...
Persistent link: https://www.econbiz.de/10012257599
We analyze the effects of a vaccination program providing free flu vaccine to individuals aged 65 or more on take-up and hospitalization. By using linked patient-general practitioner (GP) data, we implement a regression discontinuity design around the threshold at age 65. We find that the...
Persistent link: https://www.econbiz.de/10012030777